On May 14th, Zhao Haozhi, Deputy Secretary of the Qingdao Municipal Party Committee and Mayor, led officials from relevant departments directly under the city to conduct on-site research on the operation of the industrial economy and the construction of key projects in Jimo District. He emphasized the need to thoroughly study and implement General Secretary Xi Jinping's important instructions and requirements for the work in Shandong and Qingdao, adhere to promoting industrial innovation through scientific and technological innovation, vigorously develop advanced manufacturing industries, and continuously achieve new breakthroughs in the construction of key industrial chains.

According to public reports, Mayor Zhao visited a total of 4 enterprises, 1 production base, and 3 construction sites, involving industries such as automobiles, new energy and new materials, and biomedicine. These industries are also the focus of Qingdao and Jimo's layout in the field of new quality productivity. During Mayor Zhao's research trip to Jimo, he personally went to the production workshop and supporting Phase III construction project site of Qingdao Baiyang Pharmaceutical for guidance. The project includes main buildings such as the formulation building and the comprehensive building, with a construction area of approximately 28312 square meters. After completion, the project is expected to have a production capacity of 5.6 billion pieces, laying the foundation for the expansion of market demand.

Mayor Zhao has gained a detailed understanding of the progress of the project construction, the future production capacity level and product system of the enterprise, and requested relevant departments to further provide service guarantees, promote the acceleration of project construction, and ensure early completion and production. The meaning of these expressions, such as "ensuring good service guarantee," "accelerating," and "guaranteeing," is self-evident. Mayor Zhao also emphasized that new industrialization is an important battlefield for developing new quality productive forces. We must do a good job in strengthening, supplementing, and extending the industrial chain, vigorously improve the level of supporting facilities, optimize the industrial ecology, and continuously shape new advantages for industrial agglomeration development.

As a high-end R&D and manufacturing platform for sustained-release drugs under Baiyang Pharmaceutical, Qingdao Baiyang Pharmaceutical has always adhered to the lifeline of high-quality drug standards, focusing on advanced formulation technologies such as osmotic pumps, pellet coatings, and skeleton tablets. The pharmaceutical factory has repeatedly passed the cGMP certification of the US FDA with "zero defects", and multiple products are produced and sold together in China and the United States. Among them, the osmotic pump controlled release formulation metformin hydrochloride sustained-release tablets Nida ® It was launched and sold in the United States as early as 2019, and entered the national medical insurance in 2023 with unique clinical value and dosage form advantages; Celecoxib Capsules Nike ®、 Nifedipine controlled-release tablets Knight ® Wait for multiple products to be selected for national procurement.